Institut Català d'Oncologia - L'Hospitalet

L'Hospitalet de Llobregat, Barcelona 08908

0 studies enrolling now · 3 studies all time

What they study most

Advanced Malignancies, Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, Metastatic Castrate Resistant Prostate Cancer (mCRPC), NSCLC, Ovarian Cancer, Solid Tumors, Urothelial Cancer

Studies at this site

• Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing — Running, not enrolling
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling
• A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants — Completed